Cabergoline and tricuspid valve incompetence 
Cabergoline and tricuspid valve incompetence Patient Reports February 12, 2012
Cabergoline Side Effects Report #4680055-X
Cabergoline side effect was reported by a Physician from on May 17, 2005. Female patient, 61 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic atherosclerosis, cardiac murmur, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with PERMAX. Patient recovered.
Cabergoline Side Effects Report #4688540-1
Cabergoline side effect was reported by a Physician from on May 27, 2005. Female patient, 61 years of age, was diagnosed with restless legs syndrome, rheumatic fever and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic atherosclerosis, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with PERMAX. Patient recovered.
Cabergoline Side Effects Report #5502491-1
Cabergoline side effect was reported by a Physician from GERMANY on Oct 18, 2007. Female patient, weighting 132.3 lb, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, left ventricular dysfunction, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence. Cabergoline dosage: DAILY DOSE:10MG. Patient recovered.
Cabergoline Side Effects Report #4966139-7
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Mar 27, 2006. Female patient, 81 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic valve incompetence, aortic valve sclerosis, dilatation atrial, left ventricular failure, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with AMANTADINE, NACOM. Patient recovered.Cabergoline Side Effects Report #4594907-2
Cabergoline side effect was reported by a Physician from on Feb 10, 2005. Male patient, 76 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: ascites, congestive cardiomyopathy, fall , oedema peripheral, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with BROMOCRIPTINE MESYLATE, NULYTELY, FUROSEMIDE, ASPIRIN, SPIRONOLACTONE, MADOPAR, SOTALOL, LEKOVIT CA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4626909-1
Cabergoline side effect was reported by a Physician from on Mar 21, 2005. Female patient, 74 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure acute, diarrhoea, dilatation atrial, hypertension, mitral valve incompetence, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4658886-1
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure systolic increased, cardiac failure, mitral valve prolapse, oedema peripheral, pleural effusion, pulmonary valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4870603-9
Cabergoline side effect was reported by a Physician from GERMANY on Dec 19, 2005. Male patient, 71 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, left ventricular failure, mitral valve incompetence, pleural effusion, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with LEVODOPA, AMANTADINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4659075-7
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Female patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4659129-5
Cabergoline side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: (3 MG), ORAL. During the same period patient was treated with SINEMET, ATORVASTATIN CALCIUM, LEVOTHYROXINE, LAMOTRIGINE, ZOPICLONE. Patient recovered.Cabergoline Side Effects Report #4917899-2
Cabergoline side effect was reported by a Consumer or non-health professional from SWEDEN on Feb 06, 2006. Female patient, 69 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac murmur, mitral valve incompetence, nightmare, pulmonary hypertension , tricuspid valve incompetence, visual disturbance. Cabergoline dosage: 4 MG (1 D), ORAL. During the same period patient was treated with ZOLOFT, MADOPARK, TOLTERODINE TARTRATE. Patient recovered.Cabergoline Side Effects Report #4844972-X
Cabergoline side effect was reported by a Physician from SWEDEN on Nov 18, 2005. Male patient, 67 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial septal defect, cardiac valve disease, musculoskeletal stiffness, osteitis, pleurisy, prostate cancer , right ventricular failure, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with MADOPARK, REMERON, SINEMET, LEVODOPA, ELDEPRYL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4577451-8
Cabergoline side effect was reported by a Physician from on Jan 26, 2005. Male patient, 66 years of age, weighting 121.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dizziness , dyspnoea, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG (2 MG, ) , ORAL. During the same period patient was treated with MADOPAR, ENTACAPNE. Patient recovered.Cabergoline Side Effects Report #4933991-0
Cabergoline side effect was reported by a Physician from GERMANY on Feb 21, 2006. Female patient, 64 years of age, weighting 160.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, hypertension, mitral valve incompetence, pulmonary valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 8 MG (4 MG, 2 IN 1 D), ORAL. During the same period patient was treated with AMANTADINE, LEVOTHYROXINE, PRESOMEN COMPOSITUM, LISINOPRIL, DIOVAN HCT, BISOPROLOL, NITRENDIPINE, SIMVASTATIN. Patient recovered.Cabergoline Side Effects Report #4896417-1
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Jan 17, 2006. Female patient, 62 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, EVERY DAY), ORAL. During the same period patient was treated with FUROSEMIDE, PERINDOPRIL, SPIRONOLACTONE, SALMETEROL, SALBUTAMOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4659578-5
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Male patient, 61 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 9 MG , ORAL. During the same period patient was treated with MADOPAR, SINEMET. Patient recovered.Cabergoline Side Effects Report #4680702-2
Cabergoline side effect was reported by a Physician from on May 20, 2005. Female patient, 61 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, chest discomfort, palpitations, pulmonary arterial pressure increased, tricuspid valve incompetence. Cabergoline dosage: 4 MG (2 MG, EVERY DAY), ORAL. During the same period patient was treated with MADOPARK, PROPRANOLOL, ELDEPRYL. Patient recovered.Cabergoline Side Effects Report #4638459-7
Cabergoline side effect was reported by a Physician from on Apr 04, 2005. Male patient, 58 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: fibrosis, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG 96 MG, INTERVAL: DAILY), ORAL. During the same period patient was treated with SINEMET, SELEGILINE HYDROCHLORIDE, SIMVASTATIN, TRANDOLAPRIL, RISPERDAL, AMIODARONE, FUROSEMIDE, CARVEDILOL. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4987994-0
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Apr 19, 2006. Male patient, 58 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, cardiac procedure complication, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence, tricuspid valve sclerosis. Cabergoline dosage: 6 MG (6 MG, 1 D), ORAL. During the same period patient was treated with SINEMET, ELDEPRYL, SIMVASTATIN, ODRIK, SPIRONOLACTONE, CORDARONE, FUROSEMIDE, DIMITONE. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #5086014-X
Cabergoline side effect was reported by a Pharmacist from SPAIN on Aug 07, 2006. Female patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: 4 MG (1 MG), ORAL. During the same period patient was treated with SELEGILINE, LEVODOPA, BENSERAZIDE, CARBIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4850529-7
Cabergoline side effect was reported by a Physician from SPAIN on Nov 30, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood lactate dehydrogenase increased, cardiomegaly, haemoptysis, mitral valve incompetence, nasopharyngitis, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with AMANTADINE, DILUTOL, MOTILIUM, SINEMET, STALEVO, BESITRAN. Patient recovered.Cabergoline Side Effects Report #4659579-7
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Female patient, 52 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG (DAILY), ORAL. Patient recovered.Cabergoline Side Effects Report #4659081-2
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Male patient, 51 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 12 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4664720-6
Cabergoline side effect was reported by a Physician from on May 06, 2005. Male patient, 51 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 12 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #5150532-6
Cabergoline side effect was reported by a Physician from SPAIN on Oct 26, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial hypertrophy, electrocardiogram st segment depression, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.Cabergoline Side Effects Report #4931009-7
Cabergoline side effect was reported by a Physician from SPAIN on Feb 14, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease
, ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.Cabergoline Side Effects Report #5165034-0
Cabergoline side effect was reported by a Physician from GERMANY on Nov 14, 2006. Male patient, 45 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, pulmonary hypertension , tricuspid valve incompetence, ventricular hypertrophy. Cabergoline dosage: 6 MG (1 D); ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, AMANTADINE, SELEGILINE, MADOPAR. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4659584-0
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Male patient, 44 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG DAILY ORAL. Patient recovered.Cabergoline Side Effects Report #6104206-5
Cabergoline side effect was reported by a Physician from SPAIN on Feb 20, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6115183-5
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6121725-6
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6124995-3
Cabergoline side effect was reported by a Physician from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.